Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02261233 · ClinicalTrials.gov registry record · NA

Osteopathic Manipulative Treatment and Postural Control: Systems Engineering Approach

A NA study, sponsored by Michigan State University.

Terminated
Registry status
NA
Development phase
63
Enrollment target

NCT02261233 is a NA study that was terminated before completion, run by Michigan State University. The registered enrollment target is 63 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02261233, a NA study, was terminated before completion, sponsored by Michigan State University.

TERMINATED
Registry status
NA
Development phase
63 participants
Enrollment target

Study Summary

The overall goal of this project is to develop sensitive and objective clinical research tools for the assessment of postural control of the trunk. In order to accomplish this goal, we aim to quantify balance performance in an unstable seated task. Specifically, the investigators will quantify balance performance in low back pain participants before and after osteopathic manipulative treatment. The investigators hypothesize that there will be a significant improvement in balance performance after a single session of osteopathic manipulative treatment as well as after 4 sessions of osteopathic manipulative treatment and this improvement will be greater than any learning effect. A secondary objective of this study is to quantify differences in patient-oriented outcome measures (e.g., self-reported pain, disability) in low back pain participants before and after osteopathic manipulative treatment. The investigators hypothesize that there will be a significant improvement in these self-reported outcomes following osteopathic manipulative treatment. The association between improvement in postural control parameters and patient-oriented measures will also be explored.

Interventions

  • PROCEDURE Osteopathic manipulative treatment

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2014-04-01
Est. Completion 2018-08-31
Phase NA

Sponsor

Michigan State University

120 total trials

What the Registry Record Tells You About NCT02261233

The ClinicalTrials.gov registry entry for NCT02261233 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Osteopathic manipulative treatment is the first listed.

NCT02261233 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02261233 about?

NCT02261233 is a clinical study titled "Osteopathic Manipulative Treatment and Postural Control: Systems Engineering Approach". The overall goal of this project is to develop sensitive and objective clinical research tools for the assessment of postural control of the trunk. In order to accomplish this goal, we aim to quantify balance performance in an unstable seated task. Specifically, the investigators will quantify balan...

What is the current status of trial NCT02261233?

This trial is currently terminated. It is a NA study. The enrollment target is 63 participants. The study started on 2014-04-01. Estimated completion is 2018-08-31.

What interventions are being tested in trial NCT02261233?

The interventions under investigation include: Osteopathic manipulative treatment (PROCEDURE).

Who is sponsoring clinical trial NCT02261233?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.